| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | -32.8% |
| R&D Expense | $32.1M | -18.8% |
| SG&A Expense | $26.7M | -16.6% |
| Operating Income | -$54.8M | +16.4% |
| Pre-tax Income | -$54.1M | +14.3% |
| Income Tax | $0 | — |
| Net Income | -$54.1M | +14.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $61.7M | +43.5% |
| Total Assets | $82.4M | +27.7% |
| Current Liabilities | $21.6M | +26.3% |
| Long-term Debt | $27.3M | +876.6% |
| Total Liabilities | $52.8M | +120.2% |
| Stockholders' Equity | $29.6M | -27.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.1M | +32.1% |
| Capital Expenditures | $3.4M | -67.7% |
| Investing Cash Flow | -$3.4M | -210.0% |
| Financing Cash Flow | $64.9M | +210.6% |
| Free Cash Flow | -$45.5M | +37.2% |